![Dorzagliatin add-on therapy to metformin in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled phase 3 trial | Nature Medicine Dorzagliatin add-on therapy to metformin in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled phase 3 trial | Nature Medicine](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41591-022-01803-5/MediaObjects/41591_2022_1803_Fig1_HTML.png)
Dorzagliatin add-on therapy to metformin in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled phase 3 trial | Nature Medicine
![Heifers with positive genetic merit for fertility traits reach puberty earlier and have a greater pregnancy rate than heifers with negative genetic merit for fertility traits - Journal of Dairy Science Heifers with positive genetic merit for fertility traits reach puberty earlier and have a greater pregnancy rate than heifers with negative genetic merit for fertility traits - Journal of Dairy Science](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/76144c96-c8dc-4e70-84da-7b948ae20a2f/gr1.jpg)
Heifers with positive genetic merit for fertility traits reach puberty earlier and have a greater pregnancy rate than heifers with negative genetic merit for fertility traits - Journal of Dairy Science
![Safety and efficacy of oral fexinidazole in children with gambiense human African trypanosomiasis: a multicentre, single-arm, open-label, phase 2–3 trial - The Lancet Global Health Safety and efficacy of oral fexinidazole in children with gambiense human African trypanosomiasis: a multicentre, single-arm, open-label, phase 2–3 trial - The Lancet Global Health](https://www.thelancet.com/cms/asset/4d18a365-6c6c-493b-b3b6-6f8e6cebd5aa/gr1.jpg)
Safety and efficacy of oral fexinidazole in children with gambiense human African trypanosomiasis: a multicentre, single-arm, open-label, phase 2–3 trial - The Lancet Global Health
![49195 - In SAS® Enterprise Guide®, you might receive an error that the data set limit has been reached 49195 - In SAS® Enterprise Guide®, you might receive an error that the data set limit has been reached](http://support.sas.com/kb/49/addl/fusion_49195_1_data_set_limit_reached.jpg)
49195 - In SAS® Enterprise Guide®, you might receive an error that the data set limit has been reached
![49195 - In SAS® Enterprise Guide®, you might receive an error that the data set limit has been reached 49195 - In SAS® Enterprise Guide®, you might receive an error that the data set limit has been reached](http://support.sas.com/kb/49/addl/fusion_49195_2_datasetoption.jpg)
49195 - In SAS® Enterprise Guide®, you might receive an error that the data set limit has been reached
![ESSD - HydroGFD3.0 (Hydrological Global Forcing Data): a 25 km global precipitation and temperature data set updated in near-real time ESSD - HydroGFD3.0 (Hydrological Global Forcing Data): a 25 km global precipitation and temperature data set updated in near-real time](https://essd.copernicus.org/articles/13/1531/2021/essd-13-1531-2021-avatar-web.png)
ESSD - HydroGFD3.0 (Hydrological Global Forcing Data): a 25 km global precipitation and temperature data set updated in near-real time
Censoring Trace-Level Environmental Data: Statistical Analysis Considerations to Limit Bias | Environmental Science & Technology
![Adebrelimab or placebo plus carboplatin and etoposide as first-line treatment for extensive-stage small-cell lung cancer (CAPSTONE-1): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial - The Lancet Oncology Adebrelimab or placebo plus carboplatin and etoposide as first-line treatment for extensive-stage small-cell lung cancer (CAPSTONE-1): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial - The Lancet Oncology](https://www.thelancet.com/cms/attachment/836ddd64-746c-42be-a466-bc87d43afc1a/gr1.gif)